Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.004 Å; disorder in main residue; R factor = 0.024; wR factor = 0.059; data-to-parameter ratio = 18.5.
In the title compound, C 10 H 9 IO, the asymmetric unit contains two molecules, in which the iodo-bearing six-membered rings adopt envelope conformations [displacements of the flap atoms = 0.419 (3) and 0.431 (3) Å ]. In both molecules, the I atoms are disordered over two set of sites in 0.54 (4):0.46 (4) and 0.71 (3):0.29 (3) ratios. In the crystal, the packing features a weak C-HÁ Á Á interaction.
Related literature
For a related structure, see: Haddad (1986) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Cg3 is the centroid of the C11-C16 ring. 
Comment
The title compound (I, Fig. 1 ) is an intermediate for the total synthesis of steroidal hormones. The ctystal structures of (II) 2,2-Dibromo-3,4-dihydro-1(2H)-naphthalenone (Haddad, 1986) has been published, which seems relavent to (I). (Table 1) .
Experimental
A solution of I 2 (7.75 g, 30.5 mmol) in CHCl 3 was added as drops to a solution of 1-tetralone (2.198 g, 15.2 mmol) in acetic acid (9.156 g, 0.1526 mol) and refluxed for 28 h. The H 2 O (30 ml) was added for partitioning. The reaction mixture was extracted with CHCl 3 (3 × 15 ml). The combined organic layer was concentrated in vacuo, the crude was dissolved in ethyl acetate, washed with 5% Na 2 S 2 O 3 (2 × 15 ml), dried over anhydrous Na 2 SO 4 , filtered, boiled with charcoal, concentrated under reduce pressure and allowed for crystallization, which afforded colourless prisms (89%) of (I).
Refinement
The other H-atoms were positioned geometrically (C-H = 0.93-0.98 Å) and refined as riding with U iso (H) = 1.2U eq (C).
Figures Fig. 1 . View of (I) with the I atoms having greater occupancies. The displacement ellipsoids are drawn at the 30% probability level.
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